Mentorship Programme

The Mentorship Programme was created as a means of enhancing scientific exchange and personal developmental relationships in which a more experienced and knowledgeable hepatologist would guide a young investigator through a crucial stage of their career path.

The programme is not simply about answering ad hoc questions or providing occasional help, it is about establishing an ongoing relationship (continuous learning, dialogue, and challenge).

Mentoring is a process that involves communication and is relationship based, it is a process enabling the informal transmission of knowledge and a means of support for the mentee that is relevant to work, career, and professional development.


mentorship awardees 2018


MARTA AFONSO                                       IULIANA NENU

                                                    MENTOR:                                                   MENTOR:
                                              DR PETER GALLE                        PROF. OLIVIER CHAZOUILLèRES



Peter R. Galle, MD, PhD

Dr. Galle majored in internal medicine at the Universities of Berlin and Marburg/Germany, Hammersmith Hospital, London/UK and University of Texas/USA and received his M.D. degree from Marburg University and Ph.D. degree from Heidelberg University.

Initially he held a position as postdoctoral fellow in Molecular Biology at the Centre for Molecular Biology Heidelberg working on the replication of hepatitis B viruses. Afterwards he completed his residency in Internal Medicine and Gastroenterology at the University Hospital of Heidelberg. In 1998 he became Director of the I. Medical Department in Mainz and from 2005 – 2008 he hold the CEO position of Mainz University Hospital.

He is member of several national and international societies such as the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL), served as Co-editor for the Journal of Hepatology and is on the Editorial Boards of several other Journals. He served as congress president of the German Society for Digestive Diseases (DGVS) in 2014. He was member of the Executive Board and President of the International Liver Cancer Association (ILCA).

His research has focused on elucidating important aspects of apoptotic cell death in the liver, immune escape of tumour cells and on clinical and molecular aspects of hepatocellular carcinoma. He was awarded several prizes, amongst others the prestigious Tannhauser award, the highest prize of the German Society for Digestive Diseases. He has published more than 500 peer-reviewed papers.

Google Scholar Citation Report         (SEP 2017)

Sum of the Times Cited:                                 47608
h-index:                                                          100

Prof. Olivier Chazouilleres, MD,

received his medical education at the Pierre and Marie Curie University in Paris, France, where he started his residency and fellowship in Hepatology and Gastroenterology. In 1991-92, he joined, as a Research fellow, the laboratory of Prof. Terry Wright at University of California, San Francisco, where he studied hepatitis B and C infections in liver transplant recipients.

Since 1998, he has been Professor of Hepatology and is currently Head of the Hepatology Department at Saint Antoine Hospital in Paris.

Professor Chazouillères’main research interests relate to the clinical aspects and management of cholestatic diseases (primary biliary cholangitis and primary sclerosing cholangitis) and autoimmune hepatitis with a special attention to non-invasive tools (transient elastometry, magnetic resonance imaging) and novel treatments.

Professor Chazouillères is past President of the French Society of Hepatology. He is a member of the American Association for the Study of Liver Disease and the European Association for the Study of the Liver (EASL). He also served as President of a committee of the French Research Agency on HIV and HCV infections. He is member of the steering committee of the International Primary Sclerosing Cholangitis Study Group.

Professor Chazouillères is investigator in a number of national and international studies in the field of cholestatic and autoimmune diseases and has served as panel member of the EASL Clinical Practice Guidelines on cholestatic disorders and autoimmune hepatitis.

Rules & conditions

EASL offers 2 mentorships per year.

The mentor/mentee relationship is to be based on a specific objective (e.g. launching a research project, acquiring new clinical skills or getting some data into publication...)

EASL will pay for 1 visit up to two weeks (flight & university / 3* accommodation) for the mentee to visit the mentor. EASL will also pay for the mentor and mentee to attend The International Liver Congress™ in April (flight, accommodation & registration) where they can meet and present their collaboration to EASL delegates. (Other meetings can be arranged as required but at the mentor's and mentee's own expense).

Duration of each programme: 12 months - no renewal is possible.

Mentees will be entitled to collaborate with one of the above-stated mentors depending on their specialty area and field of interest. Only 1 mentor per mentee and vice versa.

Conditions for Mentees

  • Mentees should be under the age of 35 at the time of application and/or still in training.
  • Applicant must be a registered EASL member.
  • Applicant must not hold a permanent position.
  • Home institution must be European and located in a different European country from the mentor's institution.
  • No restriction on the applicant's nationality.
  • Mentees and mentors will be notified by early January.
  • The mentors and mentees will be requested to attend The International Liver Congress™ in April. Both parties will take part in the Young Investigators' Forum.


  • All applications will be reviewed by the scientific committee and then sent for approval to the mentors
  • Mentorships to begin (at the latest) by January of the following year
  • The mentor-mentee relationship should last for 1 year. Extended programmes cannot be requested or accepted
  • All applications to be received in English

How to apply

Online applications should be sent to the EASL Office before 30 November each year.

During the process you will need to upload:

  • your personal details - complete CV
  • a letter detailing your interest in the mentorship program and stating the objective(s) which you, the mentee, would like to achieve
  • a letter of recommendation from a former or current supervisor

Questions regarding EASL Mentorship should be sent to

Previous Mentors-Mentees

Year Mentor Mentee
2017 Prof. Jean-Francois Dufour

Prof. Jean-Francois Dufour

University Clinic Visceral Surgery and Medicine, Switzerland


Dr Maria Chiara Sorbo


2017 Mario Strazzabosco MD, PhD

Prof. Mario Strazzabosco

Università di Milano-Bicocca & Yale School of Medicine, Italy


Dr Emma Andersson


2017 Prof. Michael Trauner, MD

Prof. Michael Trauner, MD

Division of Gastroenterology and Hepatology, Medical University of Vienna, Austria


Dr Vitor Magno Pereira


2016 Prof. Marsha Y Morgan, MD

Prof. Marsha Y Morgan, MD

Qualified in medicine with distinction and undertook her early clinical training in Manchester and London.

•	Dr. Nina Kimer, Hvidovre, Denmark

Nina Kimer,


2016 Prof. dr. U.H.W. Beuers

Prof. dr. U.H.W. Beuers

Head of Hepatology, and Professor and Programme Director of Gastroenterology and Hepatology at the Academic Medical Centre (AMC) of the University of Amsterdam.

Dr. Sharat Varma, Brussels, Belgium

Sharat Varma,


2015 Prof-Dominique-Charles-Valla

Prof. Dominique-Charles Valla

Professor of hepatology at Université Paris Diderot and Hôpital Beaujon (APHP, Clichy), Paris.

Research interests: vascular diseases of the liver in adults


Georgiana Minzala,



Prof. Michael P. Manns, MD

Director of the Department of Gastroenterology, Hepatology and Endocrinology at the Medical School of Hannover in Germany.

Research interests: viral hepatitis, autoimmune liver disease, hepatocellular carcinoma, liver transplantation, regenerative medicine, and cell therapy.


Jelena Martinov,



Prof. Dr Peter Ferenci, MD

Medical University of Vienna, Austria.

Research interests: Chronic Viral Hepatitis, Inherited Liver Diseases, Hepatic Encephalopathy

Natalia Tikhonova

Natalia Tikhonova,

Moscow, Russia


Prof. Peter L.M. Jansen, MD, PhD

Prof, Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands.

Research interests: Cholestatic and Metabolic Liver Disease

Alina Habic,

Cluj, Romania


Prof. Massimo G. Colombo, MD

Professor of Gastroenterology, University of Milan, Italy.

Research interests: diagnosis and treatment of viral hepatitis and liver cancer.



Bulent Baran,



Dr Jaime Bosch

Professor of Medicine and Chief of Hepatology Section at the IMD, Hospital Clinic, University of Barcelona, Spain.

Research interests: the pathophysiology and treatment of portal hypertension.



Bogdan Procopet,



Get notified